WALLINGFORD, Conn.--(BUSINESS WIRE)--Hitachi-Aloka, the worldwide leader in the intraoperative ultrasound market, is now endorsing the STERIS Amsco ® V-PRO ® 1, V-PRO ® 1 Plus and V-PRO ® maX ™ Low ...
Stage IV breast cancer in the community hospital setting: Primary tumor extirpation effect on overall survival. Background: Due to improved screening for early breast cancer, the percentages of small ...
The Intraoperative Ultrasound report underlines a basic synopsis of the Intraoperative Ultrasound market that entails classifications, definitions, industry chain structure, and applications. The ...
A phase I/II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP-03). The impact of diabetes mellitus ...
NB: This will be the subject of an embargoed virtual news briefing Dr Antonio Esgueva at 14.00 hrs CET on Tuesday 15 November. Barcelona, Spain: Using ultrasound to guide surgery for patients with ...